XML 17 R6.htm IDEA: XBRL DOCUMENT v3.8.0.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Cash flows from operating activities:    
Net income $ 29,198 $ 20,522
Adjustments to reconcile net income to net cash (used in) provided by operating activities:    
Tax benefit from stock-based compensation 5,541 5,221
Depreciation and amortization 129 930
Loss on disposal of fixed assets 4,045  
Impairment charges 0 (962)
Deferred taxes (12) (14)
Accrued interest on note receivable - related party 4,893 5,176
Deferred rent expense (379) 161
Marketable Securities, Realized Gain (Loss) (133)  
Realized loss (gain) on sale of marketable securities   (20)
Changes in fair value on contingent liability 0 832
Provision for Doubtful Accounts 0 7,500
Changes, net of acquisitions, in:    
Accounts receivable (19,286) 13,549
Factor accounts receivable (39,897) (41,246)
Notes receivable - related party 15,957 35,549
Repayment of Notes Receivable from Related Parties 102 103
Inventories 3,543 12,907
Prepaid expenses, prepaid taxes, deposits and other (20,371) (45,777)
Increase (Decrease) in Employee Related Liabilities (6,922) (5,736)
Increase (Decrease) in Other Accrued Liabilities 154 (182)
Net cash (used in) provided by operating activities (27,217) 8,513
Cash flows from investing activities:    
Capital expenditures (2,946) (3,293)
Purchases of marketable securities (18,203) (5,301)
Repayment of notes receivable 35,091 16,593
Acquisitions, net of cash acquired 0 (17,396)
Net cash provided by (used in) investing activities 13,942 (9,397)
Cash flows from financing activities:    
Proceeds from exercise of stock options (25,677) (33,161)
Dividends (11,758) 0
Tax benefit from the exercise of options 1,519 1,812
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability (7,000) 0
Net cash used in financing activities (42,916) (31,349)
Effect of Exchange Rate on Cash and Cash Equivalents 360 379
Net (decrease) in cash and cash equivalents (55,831) (31,854)
Cash and cash equivalents – beginning of period 181,214 126,115
Cash and cash equivalents – end of period $ 125,383 $ 94,261